SightfileU.S. market data from official filings

IRIDEX CORP (IRIX)

Name: IRIDEX CORP (IRIX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001006045 · EDGAR filings · Updated 2026-07-16

IRIDEX CORP (IRIX) has reported institutional ownership of 16.7%, with 25 institutional managers holding positions valued at $2.92M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

16.7%

Institutional managers

Reported 13F value

$2.92M

Insider activity

134 trans.

$362.5K net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-16 — Current report (8-K) filed
2026-07-14 — Insider transaction reported (Form 4)
2026-07-14 — Insider transaction reported (Form 4)
2026-07-13 — SCHEDULE 13D/A filed
2026-07-08 — Insider transaction reported (Form 4)
2026-06-18 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IRIDEX CORP has 25 institutional holders and institutional ownership of 16.7%.

Insider activity

Insiders reported 134 transactions (124 buys, 0 sells) across 6 reporting insiders, with a net reported value of $362.5K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-04-02 (recurring since 2024-05-14) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-05-20 (recurring since 2024-07-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ENLIVEX LTD COM (ENLV) · GREENLAND MINES LTD (GRML) · PDS BIOTECHNOLOGY CORP (PDSB) · Telomir Pharmaceuticals Inc (TELO) · Celularity Inc (CELU) · Lantern Pharma Inc (LTRN)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-16.